GE Healthcare, Sophia Genetics to collaborate on matching treatments to multimodal patient data and cancer type

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

GE Healthcare and Sophia Geneticshave signed a letter of intent to collaborate on advancing cancer care, with the goal of better targeting and matching treatments to each patient’s genomic profile and cancer type, helping to ensure the most effective and personalized treatment.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login